The Retina TL;DR

EP. 1: The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

ByChristina Y. Weng, MD, MBA, FASRS,Tony Stefater, MD, PhD,Tommy Stryjewski, MD

September 8th 2025

In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed to replace gas and oil tamponades.

EP. 2: The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jay S. Duker, MD

October 13th 2025

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Duker about a sustained-release tyrosine kinase inhibitor that could redefine the durability and convenience of anti-VEGF therapy.

(Image credit: Modern Retina) The Retina TL;DR: Redefining office-based surgery for retina care with Jonathan Feistmann, MD

EP. 3: The Retina TL;DR: Redefining office-based surgery for retina care with Jonathan Feistmann, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jonathan Feistmann, MD

November 1st 2025

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr Feistmann in an overview of office-based surgery, with actionable advice for retina specialists considering this approach.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Exploring neuroprotection with ONL1204 and David Zacks, MD, PhD

EP. 4: The Retina TL;DR with Dr. Weng: Targeting the Fas signaling pathway with David Zacks, MD, PhD

ByChristina Y. Weng, MD, MBA, FASRS,David Zacks, MD, PhD

January 13th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Zacks about ONL1204, a first-in-class Fas pathway inhibitor showing promise in neuroprotection for retinal diseases—from retinal detachment to geographic atrophy and glaucoma.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Tracking retinal gene therapies with Arshad M. Khanani, MD, MA, FASRS

EP. 5: The Retina TL;DR with Dr. Weng: Tracking retinal gene therapies with Arshad M. Khanani, MD, MA, FASRS

ByChristina Y. Weng, MD, MBA, FASRS,Arshad M. Khanani, MD, MA, FASRS

February 23rd 2026

In the latest episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Khanani about new retinal gene therapy trials, covering safety, delivery, and ways to reduce treatment burden.

EP. 6: The Retina TL;DR with Dr. Weng: Moving beyond anti-VEGF with OTX-TKI and Pravin U. Dugel, MD

ByChristina Y. Weng, MD, MBA, FASRS,Pravin U. Dugel, MD

March 23rd 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Dugel about the novel hydrogel-based tyrosine kinase inhibitor platform designed to extend durability and improve long-term outcomes in neovascular AMD.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Unpacking photobiomodulation for dry AMD with Diana V. Do, MD; Eleonora Lad, MD, PhD; and Marion R. Munk, MD, PhD

EP. 7: The Retina TL;DR with Dr. Weng: Unpacking photobiomodulation for dry AMD with Drs. Do, Lad, and Munk

ByChristina Y. Weng, MD, MBA, FASRS,Diana V. Do, MD, Eleonora (Nora) M. Lad, MD, PhD,Marion R. Munk, MD, PhD

April 16th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Drs. Do, Lad, and Munk about the LIGHTSITE III trial data behind photobiomodulation and what it means for retina practice.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Navigating the ocular risks of facial fillers with Jennifer Murdock, MD

EP. 8: The Retina TL;DR with Dr. Weng: Navigating the ocular risks of facial fillers with Jennifer Murdock, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jennifer Murdock, MD

May 11th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Murdock about how the rise of "Ozempic face" has placed aesthetic injectables at the intersection of oculoplastics and retina.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS

EP. 9: The Retina TL;DR with Dr. Weng: Clinical trials, career, and community with David A. Eichenbaum, MD, FASRS

ByChristina Y. Weng, MD, MBA, FASRS,David A. Eichenbaum, MD, FASRS

June 11th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Eichenbaum about the cell and gene therapy pipeline ahead, what sustains a career in retina, and why lifting others up is just what you do.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Restoring central vision in geographic atrophy with PRIMA and Frank Brodie, MD, MBA

EP. 10: The Retina TL;DR with Dr. Weng: Restoring central vision in geographic atrophy with PRIMA and Frank Brodie, MD, MBA

ByChristina Y. Weng, MD, MBA, FASRS,Frank Brodie, MD, MBA

July 16th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Brodie about a photovoltaic subretinal implant showing meaningful visual gains in patients with geographic atrophy due to AMD.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Harnessing home OCT and Protocol AO for wet AMD with Christina J. Flaxel, MD, FARVO, and Noam Rudnick, MD, PhD

EP. 11: The Retina TL;DR with Dr. Weng: Harnessing home OCT and Protocol AO for wet AMD with Christina J. Flaxel, MD, FARVO, and Noam Rudnick, MD, PhD

ByChristina Y. Weng, MD, MBA, FASRS,Christina J. Flaxel, MD, FARVO,Noam Rudnick, MD, PhD

August 15th 2026

Host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Flaxel and Dr. Rudnick about how a home monitoring device could reshape treatment decisions and reduce office visits for patients with wet AMD.